|
Jasper Therapeutics Inc (NASDAQ: JSPR) |
|
Jasper Therapeutics Inc
JSPR's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Jasper Therapeutics Inc's sales fell
in III. Quarter 2024 from the same quarter a year ago.
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 13.3 %
Jasper Therapeutics Inc net loss increased from $-16 millions, to $-19 millions in III. Quarter 2024,
• More on JSPR's Growth
|
|
Jasper Therapeutics Inc realized a net loss in trailing twelve months.
Jasper Therapeutics Inc realized cash reduction of $ -0.42 per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.99.
• More on JSPR's Valuation
|
|
|
|
|
Jasper Therapeutics Inc realized net loss in trailing twelve months.
Jasper Therapeutics Inc realized cash outflow of $ -0.42per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.99.
Jasper Therapeutics Inc Price to Book Ratio is at 1.17 higher than Industry Avg. of -0, and higher than S&P 500 Avg. of 0.01
• More on JSPR's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com